Odontoprev (Odontoprev) COGS-to-Revenue : 0.76 (As of Dec. 2023)

View and export this data going back to 2012. Start your Free Trial

What is Odontoprev COGS-to-Revenue?

Odontoprev's Cost of Goods Sold for the three months ended in Dec. 2023 was $84.3 Mil. Its Revenue for the three months ended in Dec. 2023 was $111.1 Mil.

Odontoprev's COGS to Revenue for the three months ended in Dec. 2023 was 0.76.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Odontoprev's Gross Margin % for the three months ended in Dec. 2023 was 24.16%.

Odontoprev COGS-to-Revenue Historical Data

The historical data trend for Odontoprev's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Odontoprev COGS-to-Revenue Chart

Odontoprev Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.45

0.43

0.42

0.73

0.69

Odontoprev Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
COGS-to-Revenue	Get a 7-Day Free Trial															0.80	0.80	0.63	0.69	0.76

Odontoprev COGS-to-Revenue Calculation

Odontoprev's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	298.775	/	432.399
	=	0.69

Odontoprev's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	84.282	/	111.127
	=	0.76

Odontoprev (GREY:ODPVF) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Odontoprev's Gross Margin % for the three months ended in Dec. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	84.282 / 111.127
	=	24.16 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Odontoprev COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Odontoprev's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Odontoprev (Odontoprev) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Odontoprev SA (GREY:ODPVF) » Definitions » COGS-to-Revenue

Comparable Companies

BSP:QUAL3 UNH ELV CI CVS HUM CNC MOH SZSE:000503 ALHC OSCR CLOV BHG ROCO:6665 MIL:HI TSXV:NXG PFHO MRAI

Traded in Other Exchanges

ODPV3:Brazil

Address

Avenida Marcos Penteado de Ulhoa Rodrigues, 939 - 14th Floor, section 1401, Jatoba Building, Castelo Branco Office Park, Tambore, Barueri, SP, BRA, 06460-040

Website

http://www.odontoprev.com.br

Odontoprev SA provides dental benefit plans throughout Brazil and operates a sizable network of dentists throughout the country. The firm operates in three segments based on client size as well as one auxiliary segment that includes dental care goods and services. The dental care plan segments include corporate plans with many contracts (more than 200); small and midsize, with smaller groups of contracts; and individual, which includes monthly and annual plans sold directly to individuals. The majority of Odontoprev's revenue is generated by the corporate segment.

Odontoprev (Odontoprev) Headlines

From GuruFocus

Royce International Premier Fund Semiannual Letter

By Cody Eustice Cody Eustice • 09-19-2016

Royce Investment Partners: International Small-Cap Premier Quality Strategy 1Q23 Update & Outlook

By Sydnee Gatewood • 05-02-2023

Royce Investment Partners Comments on OdontoPrev

By Sydnee Gatewood Sydnee Gatewood • 10-27-2020